Iron Overload
📧 Sign up to get email alerts when something new happens for Iron Overload.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients [Phase 4]
Phase 4 clinical trial update for treating transfusional iron overload in patients with myelodysplastic syndromes; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Cardiac T2* in Beta-thalassemia Patients on Deferasirox Treatment [Phase 2]
Phase 2 trial update on cardiac T2* in beta-thalassemia patients treated with deferasirox; results posted after completion.
-
FDA approval · 2021-04-30FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for Ferriprox (deferiprone) from Chiesi USA, Inc., signaling an approved modification to its exi…
-
FDA approval · 2021-04-30FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for Ferriprox (deferiprone) from Chiesi USA, Inc., indicating an approved change to the product’s la…
-
CLINICAL_TRIALS trial_result · 2021-04-08Clinical Trial Update: Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients [Phase 3]
Phase 3 trial comparing deferiprone to deferasirox in pediatric patients with chronic iron overload has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-03-29FDA Approved: DEFERIPRONE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a generic version of deferiprone (ANDA 213239) from Hikma Pharmaceuticals USA Inc. under an original application.
-
FDA approval · 2021-03-17FDA Approved: DEFERASOROX — Original Application (Novadoz Pharmaceuticals LLC)
The FDA granted approval for the original ANDA application of Deferasorox (deferasirox) by Novadoz Pharmaceuticals LLC as a generic product.…
-
FDA approval · 2021-03-01FDA Approved: DEFERASIROX — Supplemental Application (Dr. Reddy's Laboratories Inc)
The FDA approved a supplemental application for Deferasirox submitted by Dr. Reddy's Laboratories Inc, resulting in changes to the product's…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia [Phase 2, Phase 3]
Phase 2/Phase 3 trial evaluating hydroxyurea, omega-3, Nigella sativa, and honey for iron overload and oxidative stress in pediatric major t…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Safety Study of Crushed Deferasirox Film Coated Tablets in Pediatric Patients With Transfusional Hemosiderosis [Phase 4]
Phase 4 safety study of crushed deferasirox film-coated tablets in pediatric patients with transfusional iron overload completed; results po…
-
FDA label_change · 2020-07-23FDA Approved: JADENU — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approves a supplemental application for JADENU (deferasirox) from Novartis, updating the product labeling.
-
FDA approval · 2020-07-02FDA Approved: DEFERASIROX — Original Application (Ascend Laboratories, LLC)
FDA approved the original ANDA for a generic deferasirox (DEFERASIROX) from Ascend Laboratories, expanding access to an iron-chelating thera…
-
FDA approval · 2020-06-16FDA Approved: DEFERASIROX — Original Application (Dr. Reddy's Laboratories Inc)
FDA approves Dr. Reddy's Laboratories' deferasirox generic under ANDA210945 for the treatment of chronic iron overload due to blood transfus…
-
FDA approval · 2020-05-19FDA Approved: FERRIPROX — Original Application (Chiesi USA, Inc.)
FDA approved Ferriprox (deferiprone) through the original NDA submitted by Chiesi USA, Inc.
-
FDA approval · 2020-04-13FDA Approved: DEFERASIROX — Supplemental Application (Xiromed, LLC)
The FDA approved a supplemental application for deferasirox filed by Xiromed, LLC under an ANDA.
-
FDA approval · 2020-03-30FDA Approved: DEFERASIROX — Original Application (Ascend Laboratories, LLC)
FDA approves Deferasirox as an original ANDA submission by Ascend Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation [Phase 3]
Phase 3 trial update on extended evaluation of deferasirox film-coated tablet formulation for chronic iron overload; results posted after co…
-
FDA approval · 2020-02-20FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)
FDA approved a supplemental application for Ferriprox (deferiprone) submitted by Chiesi USA, Inc.
-
FDA approval · 2019-12-27FDA Approved: DEFERASIROX — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original application for deferasirox from Amneal Pharmaceuticals NY LLC, marking the first generic approval of deferasirox.
-
FDA approval · 2019-11-20FDA Approved: DEFERASIROX — Original Application (Alembic Pharmaceuticals Limited)
FDA approved the Original Application for Deferasirox from Alembic Pharmaceuticals Limited (ANDA211824).
-
FDA approval · 2019-11-20FDA Approved: DEFERASIROX — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's generic deferasirox tablet under an original ANDA for the treatment of chronic iron overload due to blood …
-
FDA approval · 2019-11-20FDA Approved: DEFERASIROX — Original Application (Bionpharma Inc.)
FDA approved Deferasirox as the generic version under an Original Application (ANDA) submitted by Bionpharma Inc.
-
FDA approval · 2019-11-20FDA Approved: DEFERASIROX — Original Application (Alembic Pharmaceuticals Limited)
FDA approved a generic version of deferasirox (DEFERASIROX) from Alembic Pharmaceuticals Limited under an Original Application for the treat…
-
FDA approval · 2019-11-20FDA Approved: DEFERASIROX — Original Application (Dr. Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' original application for deferasirox, a generic iron chelator used to treat chronic iron overload in …
-
FDA approval · 2019-07-25FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)
The FDA approved a supplemental application for Ferriprox (deferiprone) submitted by Chiesi USA, Inc., updating/expanding the product's labe…